Literature DB >> 24833785

Investigation of a PON1 gene polymorphism (rs662 polymorphism) as predictor of subclinical atherosclerosis in patients with rheumatoid arthritis.

Raquel López-Mejías1, Fernanda Genre1, Alfonso Corrales1, Carlos González-Juanatey2, Begoña Ubilla1, Javier Llorca3, José A Miranda-Filloy4, Trinitario Pina1, Ricardo Blanco1, Santos Castañeda5, Javier Martín6, Miguel A González-Gay1.   

Abstract

Entities:  

Keywords:  Atherosclerosis; Gene Polymorphism; Rheumatoid Arthritis

Mesh：

Substances：

Year:  2014        PMID： 24833785     DOI： 10.1136/annrheumdis-2014-205543

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Can the ankle brachial pressure index (ABPI) and carotis intima media thickness (CIMT) be new early stage markers of subclinical atherosclerosis in patients with rheumatoid arthritis?

Authors:  Tolga Kurt; Ahmet Temiz; Ferhat Gokmen; Gurhan Adam; Sedat Ozcan; Ersan Ozbudak; Mustafa Sacar
Journal:  Wien Klin Wochenschr       Date:  2015-03-17       Impact factor: 1.704

2.  Correlation of Paraoxonase Status with Disease Activity Score and Systemic Inflammation in Rheumatoid Arthritic Patients.

Authors:  Usha Dudeja Bindal; Rahul Saxena; Merajul Haque Siddiqui; Dilutpal Sharma
Journal:  J Clin Diagn Res       Date:  2016-03-01

3.  PON-1 haplotype (-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients.

Authors:  Oscar Zaragoza-García; Iris Paola Guzmán-Guzmán; Ma Elena Moreno-Godínez; José Eduardo Navarro-Zarza; Verónica Antonio-Vejar; Mónica Ramírez; Isela Parra-Rojas
Journal:  Clin Rheumatol       Date:  2020-06-18       Impact factor: 2.980

4.  A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study.

Authors:  Cecilia P Chung; Joseph F Solus; Annette Oeser; Chun Li; Paolo Raggi; Jeffrey R Smith; C Michael Stein
Journal:  Int J Mol Sci       Date:  2015-02-11       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.